Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03284021

Fraxel Laser for Alopecia

A Pilot Study on 1550 nm Fractional Erbium-glass Laser for Alopecia Treatment

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a pilot study to evaluate the effect of the 1550 nm fractional erbium-glass laser in patients with nonscarring alopecias. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. Participants will receive 5 sessions of laser, 30 days apart, to the area of alopecia on the scalp. Follow-up is at 150 days. This study was a pilot study designed to determine feasibility of this procedure.

Conditions

Interventions

TypeNameDescription
DEVICEFractional erbium-glass 1550 nm laserThe fractional erbium-glass 1550 nm laser will be applied to the previously 100 cm2 determined area of the scalp with the following parameters: 5-10 mm tip, 5-10 mJ, pulse energy 500-1500 MTZ/cm2 density, one to twopasses, static mode.

Timeline

Start date
2019-04-24
Primary completion
2019-04-24
Completion
2019-04-24
First posted
2017-09-15
Last updated
2021-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03284021. Inclusion in this directory is not an endorsement.